BetaBlue, Inc. logo

BetaBlue, Inc.

BetaBlue, Inc. is a developmental stage biopharmaceutical company that is developing novel small molecule therapeutics that exhibit functional selectivity at clinically relevant dopamine receptors to treat neurological illness.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.beta-blue.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
420 Water Shadow Ln, GA, 30022-4035
Alpharetta
United States
Email
Contact Number
+1 770-337-2390

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/betablue” connections=”true” suffix=””]